...
首页> 外文期刊>Biocell >EXPRESSION OF BIOACTIVE FUSION PROTEINS OF E. COLI HEAT-LABILE TOXIN B SUBUNIT AND SYNAPSIN PEPTIDES
【24h】

EXPRESSION OF BIOACTIVE FUSION PROTEINS OF E. COLI HEAT-LABILE TOXIN B SUBUNIT AND SYNAPSIN PEPTIDES

机译:大肠埃希菌热毒素B亚单位和突触肽肽生物融合蛋白的表达

获取原文
获取原文并翻译 | 示例

摘要

Pentameric B subunit of E. coli heat-labile toxin (LTB) mediates holotoxin binding to host cell membranes and has been used as efficient mucosal carrier of chemically or genetically coupled antigens. We constructed two recombinant hybrid molecules by fusing the N-terminal of C (residues 113-308) and ABC (residues 1-308) domains of rat synapsin to the C-terminus of LTB. Both LTBSC and LTBSABC fusion proteins were inductively expressed as cytoplasmic inclusion bodies in E. coli and then purified by affinity chromatography on Ni-agarose under denaturant conditions. For in vitro refolding and oligomerization of the hybrid proteins dialysis and dilution were assayed to decrease denaturant concentration. We examined the effect of several conditions regarding redox environment and presence of L-arginine in refolding buffer. About 97 % of LTBSABC and 90% of LTBSC were recovered soluble in 0.05 M Tris buffer pH 8 containing 2 M urea. Both of them retained the ability to bind to GM1 receptor in an enzyme-linked immunosorbent assay. Also LTBSC induced oral tolerance when fed to rats before active immunization as it was shown by inhibition of the specific DTH response and in vivo and in vitro cell proliferation. These results strongly suggest that these fusion proteins are suitable for exploring mucosal adjuvant activity in autoimmune disorders involving antigens from central nervous system.
机译:大肠杆菌热不稳定毒素(LTB)的五聚体B亚基介导全毒素与宿主细胞膜的结合,已被用作化学或遗传偶联抗原的有效粘膜载体。我们通过将大鼠突触蛋白的C(残基113-308)和ABC(残基1-308)结构域的N末端融合到LTB的C末端,构建了两个重组杂合分子。 LTBSC和LTBSABC融合蛋白均在大肠杆菌中被诱导表达为细胞质包涵体,然后在变性条件下在Ni-琼脂糖上通过亲和层析纯化。为了进行杂合蛋白的体外重折叠和寡聚化,分析透析和稀释以降低变性剂浓度。我们研究了有关氧化还原环境和重折叠缓冲液中L-精氨酸存在的几种条件的影响。回收到约97%的LTBSABC和90%的LTBSC可溶于含2M尿素的0.05M Tris缓冲液pH 8中。在酶联免疫吸附测定中,它们都保留了与GM1受体结合的能力。在主动免疫之前喂给大鼠时,LTBSC也会诱导口服耐受,这是通过抑制特异性DTH反应以及体内和体外细胞增殖来表明的。这些结果强烈表明,这些融合蛋白适合在涉及中枢神经系统抗原的自身免疫性疾病中探索粘膜佐剂活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号